Daniel Burzon

980 total citations
9 papers, 616 citations indexed

About

Daniel Burzon is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Daniel Burzon has authored 9 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Daniel Burzon's work include Renal and Vascular Pathologies (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Pediatric Urology and Nephrology Studies (3 papers). Daniel Burzon is often cited by papers focused on Renal and Vascular Pathologies (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Pediatric Urology and Nephrology Studies (3 papers). Daniel Burzon collaborates with scholars based in United States. Daniel Burzon's co-authors include Gary Bokinsky, Michael M. Lieber, Mark S. Soloway, Roberto Chao, Michael F. Sarosdy, Julia A. Bridge, Kerry Flom, Sonny L. Johansson, Steven M. Anderson and Joseph Zadra and has published in prestigious journals such as The Journal of Urology, Urology and PubMed.

In The Last Decade

Daniel Burzon

9 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Burzon United States	6	392	176	119	106	69	9	616
Shinji Kurosaka Japan	14	93 0.2×	185 1.1×	123 1.0×	38 0.4×	61 0.9×	29	406
Christoph Ausch Austria	13	237 0.6×	99 0.6×	209 1.8×	44 0.4×	87 1.3×	29	660
Tsunetada Yazaki Japan	13	131 0.3×	187 1.1×	170 1.4×	21 0.2×	38 0.6×	58	497
Toshiaki Shinka Japan	12	224 0.6×	169 1.0×	161 1.4×	66 0.6×	50 0.7×	33	554
M. Takashi Japan	13	252 0.6×	152 0.9×	196 1.6×	64 0.6×	30 0.4×	37	501
Jacques F. Bogdanowicz Netherlands	8	66 0.2×	197 1.1×	83 0.7×	29 0.3×	46 0.7×	15	355
Anita Sgrignoli United States	7	141 0.4×	120 0.7×	170 1.4×	13 0.1×	28 0.4×	7	518
A. Thanos Greece	9	102 0.3×	80 0.5×	67 0.6×	67 0.6×	27 0.4×	26	303
S. Birkenhake Germany	9	238 0.6×	58 0.3×	83 0.7×	98 0.9×	75 1.1×	19	411
Jun Kurokawa Japan	9	83 0.2×	36 0.2×	117 1.0×	28 0.3×	32 0.5×	18	493

Countries citing papers authored by Daniel Burzon

Since Specialization

Citations

This map shows the geographic impact of Daniel Burzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Burzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Burzon more than expected).

Fields of papers citing papers by Daniel Burzon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Burzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Burzon. The network helps show where Daniel Burzon may publish in the future.

Co-authorship network of co-authors of Daniel Burzon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Burzon. A scholar is included among the top collaborators of Daniel Burzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Burzon. Daniel Burzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Price, David T., Barry Stein, Paul Sieber, et al.. (2006). Toremifene for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia: Results of a Double-Blind, Placebo Controlled, Phase IIB Clinical Trial. The Journal of Urology. 176(3). 965–971. 119 indexed citations

2.

Burzon, Daniel, et al.. (2005). 673: Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) Remain at High Risk for Prostate Cancer Regardless of whether HGPIN is Detected on Subsequent Biopsies. The Journal of Urology. 173(4S). 184–184. 3 indexed citations

3.

Sarosdy, Michael F., Paul F. Schellhammer, Gary Bokinsky, et al.. (2002). Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer. The Journal of Urology. 168(5). 1950–1954. 194 indexed citations

4.

Sarosdy, Michael F., Paul F. Schellhammer, Gary Bokinsky, et al.. (2002). Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.. PubMed. 168(5). 1950–4. 214 indexed citations

5.

Sarosdy, Michael F., Paul F. Schellhammer, Gary Bokinsky, et al.. (2002). Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer. The Journal of Urology. 1950–1954. 2 indexed citations

6.

Ertürk, Erdal, Daniel Burzon, & David L. Waldman. (1999). TREATMENT OF TRANSPLANT URETERAL STENOSIS WITH ENDOURETEROTOMY. The Journal of Urology. 412–414. 1 indexed citations

7.

Ertürk, Erdal, Daniel Burzon, & David L. Waldman. (1999). TREATMENT OF TRANSPLANT URETERAL STENOSIS WITH ENDOURETEROTOMY. The Journal of Urology. 161(2). 412–414. 20 indexed citations

8.

Ertürk, Erdal, Daniel Burzon, Mark S. Orloff, & Ronald Rabinowitz. (1998). Outcome of patients with vesicoureteral reflux after renal transplantation: the effect of pretransplantation surgery on posttransplant urinary tract infections. Urology. 51(5). 27–30. 31 indexed citations

9.

Wu, Guan, Daniel Burzon, Susan R. Schoen, et al.. (1996). Calcitonin receptor mrna expression in the human prostate. Urology. 47(3). 376–381. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact